MARKETS
Earnings

Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate

Aug 13, 2026 · 06:01 AM ET· updated 1h ago

Rockwell Medical (NASDAQ:RMTI) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.23) by 82.61 percent. This is a 300 percent decrease over losses of $(0.01) per share from

Share
Why It Matters

Rockwell Medical lost less money per share than expected, which is good news—but their total sales were slightly lower than what people predicted. When a company loses less money, it hints they're getting better at controlling costs, even if sales weren't quite strong enough.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.